Top
image credit: FP_atkwork / Freepik

Sofwave Medical secures FDA clearance for skin laxity improvement device

December 27, 2023

Category:

The US Food and Drug Administration (FDA) has expanded clearance to Sofwave Medical’s technology to improve the appearance of skin laxity on the upper arm.

The synchronous ultrasound parallel beam (SUPERB) technology delivers pulsed energy to collagen located in the deeper skin layers. The heat energy induces a wound-healing response involving neo-collagenisis and neo-elastogenesis – both of which lead to a reduction in fine lines and wrinkles.

Read More on Medical Device Network